UK's largest Centre for Prostate Brachytherapy with +2000 successful treatments for prostate cancer without the need for radical surgery
Simply stated, the data consistently shows that for low, intermediate, and high risk prostate cancer the cure rates for prostate seed implant are comparable or better to any other treatment option. Prostate Cancer Study Group Results Low Risk ...
Cancer cure rates after brachytherapy are comparable to surgery or external beam therapy (EBT). Demand for brachytherapy is increasing because of an increase in prevalence of various type of cancers, low treatment time and high efficiency. Its treatment results also show an increasing cure ...
PO-218 125I BRACHYTHERAPY AS A CURE FOR EARLY STAGE PROSTATE CANCER IN PATIENTS UNDER 65 YEARS OF AGEdoi:10.1016/S0167-8140(12)72184-9T. PalloniF.P. MangiacottiA. PetrucciG. BakacsM. MartiniR. ConsortiP. SoldiniD. CuccoliM. Sereni...
However, they stated that more data with large-scale randomized/prospective controlled trials and longer follow-up are needed to evaluate the safety and effectiveness of HDR-BT, and to compare it directly with external beam therapy as well as the differential cure rates of subtypes of basal cell...
Long-term studies using BMS revealed improved, yet still significant, rates of restenosis (17%–20%) ( 3 – 5 ). Therefore, in the late 1990s, newer therapies including intra-coronary brachytherapy (ICB) were developed in attempts to treat in-stent restenosis (ISR). Initial studies using ...
Temporary iridium-192 implant in the management of carcinoma of the prostate. Cancer 1992; 69: 2515–2524. CrossRef Mate TP, Gottesman JE, Hatton J, et al. High dosed-rate after-loading iridium-192 prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys 1998; 41: 525–...
p>Modern intracavitary brachytherapy carefully combined with megavoltage external beam radiotherapy is responsible for the high cure rates achieved with ra... Eifel,J Patricia - 《Journal of Surgical Oncology》 被引量: 12发表: 2015年 Infusional brachytherapy hi the treatment of head and neck-cancer...
To estimate dose rates delivered by using radioactive ^198 Au nanoparticles for prostate cancer nanobrachytherapy, identifying contribution by ... LV Angelocci,SS Sgrignoli,CDD Souza,... - IOP Publishing Ltd 被引量: 0发表: 2024年 Development and preclinical evaluation of intrinsically radiolabeled ...